Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Common Stock · CUSIP: 23284F105
Event date: 2026-09-30
- Filing-level shares
- 11,867,012.00
- Percent of class
- 5.4%
- BANK OF AMERICA CORP /DE/
Shares: 11,867,012.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-26-000528
- Form type
- SCHEDULE 13G/A
- Filer
- CytomX Therapeutics, Inc.
- CIK
- CIK 1501989
- Filed
- Oct 28, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership